Product Information
ORACIT ORAL SOLUTION is a generic product labeled by CMP Pharma, Inc., priced at $0.0768 per ML under NDC 46287001401. Its NADAC has been published 94 times since Dec 18, 2024.
Strength
640; 490 mg/5mL; mg/5mL
Manufacturer
CMP Pharma, Inc.NDC
46287001401
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATEApproval Type
Unapproved
On Market Since
5/15/1984
Pharmacological Classes
Price Statistics
The NADAC for ORACIT ORAL SOLUTION has been published 94 times since Dec 18, 2024, and over the history we have for it it has declined 4.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0768 per ML |
|---|---|
| All-time high | $0.0809 (Feb 12, 2025) |
| All-time low | $0.0713 (Jun 17, 2026) |
| 52-week high | $0.0779 |
| 52-week low | $0.0713 |
| Median price | $0.0758 |
| Average price | $0.0757 |
| Largest weekly change | +4.0% (Sep 23, 2026) |
| Weeks tracked | 94 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Citric Acid and Sodium Citrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
CMP Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Citric Acid and Sodium Citrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-coagulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ORACIT ORAL SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for ORACIT ORAL SOLUTION, manufactured by CMP Pharma, Inc., is $0.0768 per ML (NDC 46287001401), effective Sep 30, 2026.
How has the price of ORACIT ORAL SOLUTION changed over time?
Over the history we have for it, the NADAC for ORACIT ORAL SOLUTION has declined 4.9%. It has been tracked across 94 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for ORACIT ORAL SOLUTION?
Since Dec 18, 2024, the NADAC for ORACIT ORAL SOLUTION has ranged from a low of $0.0713 (Jun 17, 2026) to a high of $0.0809 (Feb 12, 2025), with a median of $0.0758 per ML.
Are there cheaper alternatives to ORACIT ORAL SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of ORACIT ORAL SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ORACIT ORAL SOLUTION?
ORACIT ORAL SOLUTION (NDC 46287001401) is labeled by CMP Pharma, Inc., and CMS classifies it as a generic product.